Continued understanding how of the interactions of Paip2 and Pabp, and of Paip2 and EDD1 are regulated should augment our understanding of how efficient translation initiation is controlled and promote the development of novel anti-cancer therapeutic agents. The gene discussed is PAIP2; the disease is cancer.